Open AccessAcellbia® and Mabtera® are recognize CD20-positive cells with equal efficiency
Author(s) -
В. А. Мисюрин,
А. В. Мисюрин,
А Е Мисюрина,
Ю. П. Финашутина,
М А Барышникова,
О. С. Бурова,
С. К. Кравченко
Publication year - 2015
Publication title -
onkogematologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.118
H-Index - 3
eISSN - 2413-4023
pISSN - 1818-8346
DOI - 10.17650/1818-8346-2015-10-4-56-59
Subject(s) - cd20 , flow cytometry , antibody , chronic lymphocytic leukemia , rituximab , biosimilar , immunoglobulin light chain , microbiology and biotechnology , chemistry , immunology , leukemia , medicine , biology